NCT06124261 Androgens and NAFLD Longitudinal Cohort Study
| NCT ID | NCT06124261 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | PCOS |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-01-22 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-01-22 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring. Young women with a condition called polycystic ovary syndrome (PCOS) have a high risk for NAFLD, and they often have high androgen levels too. So the researchers are recruiting young women with PCOS as well as those without PCOS, and will compare changes in NAFLD over time between young women with and without PCOS. This study is funded by the National Institutes of Health
Eligibility Criteria
Inclusion Criteria: * Metabolic associated steatohepatitis (MASH) (formerly NASH) * PCOS * Non-PCOS Exclusion Criteria: * High levels of alcohol use (more than 7 drinks a week) * Current pregnancy * Other causes of hepatic steatosis * Weight loss of more than 10% body weight in the last 6 months
Contact & Investigator
Monika A Sarkar, M.D., M.A.S
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06124261 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 42 Years, studying PCOS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06124261 currently recruiting?
Yes, NCT06124261 is actively recruiting participants. Contact the research team at myliverhealth@ucsf.edu for enrollment information.
Where is the NCT06124261 trial being conducted?
This trial is being conducted at San Francisco, United States, Durham, United States.
Who is sponsoring the NCT06124261 clinical trial?
NCT06124261 is sponsored by University of California, San Francisco. The principal investigator is Monika A Sarkar, M.D., M.A.S at University of California, San Francisco. The trial plans to enroll 150 participants.